Viome Life Sciences has unveiled an at-home testing kit called Oral Health Pro designed for both patients and dental professionals. This test utilizes a patient’s saliva to assess gene expressions and cells present in the oral cavity.
By analyzing the collected samples, the test is reportedly able to provide valuable insights into various aspects of oral health, including markers for oral diseases such as oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC). Notably, according to a press release, Viome reports a cancer-free specificity of greater than or equal to 95%, with OSCC and OPSCC sensitivity exceeding 90%.
RNA Sequencing and AI for Diagnostic Accuracy
Oral Health Pro harnesses Viome’s proprietary RNA sequencing technology and artificial intelligence (AI) platform. This combination enables the identification of underlying signals that may be overlooked by other tests, says Viome. By leveraging RNA sequencing and AI, the test aims to enhance diagnostic accuracy, providing comprehensive information about a patient’s oral health status.
Once patients have completed the saliva test, they can send their samples to Viome’s laboratory for analysis. Viome will then measure various markers and molecular features associated with OSCC and OPSCC. In addition to standard results, Viome offers patients a personalized treatment plan, aiming to facilitate closer collaboration between healthcare providers and their patients.
Oral Health Scores
One of the key features of Oral Health Pro is the provision of Oral Health Scores. These scores enable clinicians to identify areas where patients may require improvement or assistance. By analyzing the results and Oral Health Scores, dental professionals can develop tailored treatment solutions that address the specific oral health needs of their patients.
Patients can expect to receive their results within a timeframe of up to four weeks. By harnessing the power of RNA sequencing technology and AI analysis, this at-home testing kit is said to equip patients and dental professionals with essential insights for developing optimal, personalized treatment solutions. The integration of innovative technology and collaborative care holds the potential to improve oral health outcomes and enhance patient well-being.
Click here for more information on the Oral Health Pro by Viome Life Sciences.
The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.
Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.
The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.